Breast

Viewing Page 3 of 5 | Showing Results 21 - 30 of 42

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to observation in treating...

Alison Conlin, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

A011401: (Breast Cancer Weight Loss Study - BWEL Study): Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence)....

Timothy Byun, M.D.
  • St. Joseph Hospital of Orange
  • xSJH Southern California

A Phase II Trial Assessing The Tolerability Of Palbociclib In Combination With Letrozole or Fulvestrant in patients aged 70 and older with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer

This phase II trial studies the side effects and how well palbociclib and letrozole or fulvestrant works in treating patients aged 70 years and...

Alison Conlin, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

VERONICA A Phase II, Multicenter, Randomized study to compare the efficacy of Venetoclax plus Fulvestrant versus Fulvestrant in women with estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer who experienced disease recurrence or progression during or after CDK4/6 inhibitor therapy.

This is a Phase II, multicenter, open-label, randomized study to compare the efficacy of venetoclax in combination with fulvestrant compared with...

Ajay Kundra, M.D.
  • Providence Regional Cancer Partnership - Everett

A Phase II Study of Nivolumab Combined With Bicalutamide and Ipilimumab in Metastatic HER2-negative Breast Cancer

The goal of this protocol is to evaluate the safety and efficacy of an alternative systemic combination approach that omits or delays the use of...

David Page, M.D.
  • Memorial Sloan Kettering (MSK)
  • Oncology and Hematology Care Westside
  • Providence Cancer Institute Franz Clinic

I3Y-MC-JPCF/B-58A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

The purpose of the study is to determine if administration of the investigational drug, abemaciclib, in addition to adjuvant endocrine therapy...

Stavroula Otis, M.D.
  • xSJH Southern California

Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor...

Gary Goodman, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

Evaluating immunologic tumor-based biomarkers in early stage breast cancer and immune-based assays as biomarkers of response to systemic therapy in breast cancer

In this study, we wish to prospectively collect peripheral blood from women with breast cancer who are treated with standard therapies (for...

David Page, M.D.
  • Providence Cancer Institute Franz Clinic
Viewing Page 3 of 5 | Showing Results 21 - 30 of 42